Live Terminal | Security Analysis of MLTX
TERMINAL beta
Version: 0.1
Timestamp: 1709194396.775969
Options
0Q3.F
53.76%
006220.KS
49.51%
B7J.DE
48.43%
000540.KS
48.07%
BBAI-WT
47.26%
HANA.L
-44.06%
PHLL.L
-50.14%
RAL.PA
-52.20%
GOLL4.SA
-52.40%
HGEN.L
-54.91%
AAPL $180.88 -0.96%
AMD $176.37 -0.92%
AMZN $173.96 0.24%
BRK-B $413.02 1.01%
GOOG $137.26 -2.03%
IBM $184.92 0.03%
INTC $42.16 -1.35%
JNJ $161.21 0.14%
JPM $184.74 0.70%
META $487.18 0.03%
MSFT $407.70 0.05%
O $52.16 -0.28%
TSLA $203.55 1.91%
WMT $59.72 0.21%
QQQ $435.27 -0.5325%
TLT $93.52 0.6349%
VUSA.DE $88.94 0.3317%
VUAA.DE $88.27 0.2863%
FJPR.L $5.63 -0.5650%
VWRP.L $97.51 -0.0102%
VWRL.L $98.20 0.0255%
EMGU.L $3.55 -1.1847%
RDVY $52.62 -0.1518%
FLOT $51.04 0.0294%
SCHZ $45.68 0.2414%
IBB $139.42 -1.0434%
C020.DE $21.34 0.0000%
DFAX $24.53 -0.6480%
LYP6.DE $224.95 -0.3985%
MEUD.PA $225.01 -0.2880%
IQQW.DE $65.41 0.0643%
IDWR.L $70.89 -0.0775%
EXS1.DE $147.20 0.2452%
XESC.L $6900.00 0.0290%
DFAU $35.18 -0.2269%
ACWV $103.29 -0.3377%
VHYD.L $63.68 -0.2897%
VGWD.DE $58.77 -0.1699%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
MLTX
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
MLTX
Latest Performance
MLTX$55.35
$0.59 • 1.08%
MLTX
Price 55.35
Change Pct 1.08
Change Abs 0.59
Market Cap 3.3 billion
Eps -1.06
Pe Ratio -52.22
Outstanding Shares 59.9 million
Volume 320497
Avg Volume 486024
Industry Biotechnology
Sector Name Health Care
Country Short Name CH
Announcement Earnings 2024-03-20 00:00:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Competitors/Peer Groups
MLTX
Same Country:
Same Decade:
Intraday: -2.18%
Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
MLTX

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.